Impaired wound healing and angiogenesis in eNOS-deficient mice.

A role for nitric oxide (NO) in wound healing has been proposed; however, the absolute requirement of NO for wound healing in vivo and the contribution of endothelial NO synthase (eNOS) have not been determined. Experiments were carried out using eNOS gene knockout (KO) mice to determine the requirement for eNOS on wound closure and wound strength. Excisional wound closure was significantly delayed in the eNOS KO mice (29.4 +/- 2.2 days) compared with wild-type (WT) controls (20.2 +/- 0.4 days). At 10 days, incisional wound tensile strength demonstrated a 38% reduction in the eNOS KO mice. Because effective wound repair requires growth factor-stimulated angiogenesis, in vitro and in vivo angiogenesis assays were performed in the mice to assess the effects of eNOS deficiency on angiogenesis. Endothelial cell sprouting assays confirmed in vitro that eNOS is required for proper endothelial cell migration, proliferation, and differentiation. Aortic segments harvested from eNOS KO mice cultured with Matrigel demonstrated a significant reduction in endothelial cell sprouting and [(3)H]thymidine incorporation compared with WT mice at 5 days. Capillary ingrowth into subcutaneously implanted Matrigel plugs was significantly reduced in eNOS KO mice (2.67 +/- 0.33 vessels/plug) compared with WT mice (10.17 +/- 0.79 vessels/plug). These results clearly show that eNOS plays a significant role in facilitating wound repair and growth factor-stimulated angiogenesis.

[1]  J. Isner,et al.  Role of endothelial nitric oxide synthase in endothelial cell migration. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[2]  M. Leader,et al.  Diphenylhydantoin sodium promotes early and marked angiogenesis and results in increased collagen deposition and tensile strength in healing wounds. , 1998, Surgery.

[3]  D. Steed,et al.  Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. , 1998, The Journal of clinical investigation.

[4]  P. Huang,et al.  Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. , 1998, The Journal of clinical investigation.

[5]  H. Kleinman,et al.  Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing. , 1998, Journal of Immunology.

[6]  G. Garcı́a-Cardeña,et al.  Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. , 1997, The Journal of clinical investigation.

[7]  I. Kullo,et al.  Enhanced endothelium-dependent relaxations after gene transfer of recombinant endothelial nitric oxide synthase to rabbit carotid arteries. , 1997, Hypertension.

[8]  T. Billiar,et al.  Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. , 1997, Surgery.

[9]  R Bicknell,et al.  Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. , 1997, The Journal of clinical investigation.

[10]  Paul Martin,et al.  Wound Healing--Aiming for Perfect Skin Regeneration , 1997, Science.

[11]  M. Nehls,et al.  Suppression of Apoptosis by Nitric Oxide via Inhibition of Interleukin-1β–converting Enzyme (ICE)-like and Cysteine Protease Protein (CPP)-32–like Proteases , 1997, The Journal of experimental medicine.

[12]  H. S. Kim,et al.  Elevated blood pressures in mice lacking endothelial nitric oxide synthase. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[13]  D. Maguire,et al.  A novel in vitro assay for human angiogenesis. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[14]  D. Smith,et al.  Enhancement of wound repair with a topically applied nitric oxide‐releasing polymer , 1996, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[15]  U. Tantry,et al.  Nitric oxide regulates wound healing. , 1996, The Journal of surgical research.

[16]  M. Longaker,et al.  Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. , 1995, The Journal of Biological Chemistry.

[17]  S Amerini,et al.  Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. , 1994, The Journal of clinical investigation.

[18]  A. Koch,et al.  Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  A. Barbul,et al.  Arginine stimulates wound healing and immune function in elderly human beings. , 1993, Surgery.

[20]  M. Dyson,et al.  Comparison of the effects of moist and dry conditions on the process of angiogenesis during dermal repair. , 1992, The Journal of investigative dermatology.

[21]  H. Dvorak,et al.  Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing , 1992, The Journal of experimental medicine.

[22]  F. Luyten,et al.  Identification of multiple active growth factors in basement membrane Matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. , 1992, Experimental cell research.

[23]  F. Arnold,et al.  Angiogenesis in wound healing. , 1991, Pharmacology & therapeutics.

[24]  R. Nicosia,et al.  Growth of microvessels in serum-free matrix culture of rat aorta. A quantitative assay of angiogenesis in vitro. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[25]  M. Caldwell,et al.  Temporal expression of different pathways of 1-arginine metabolism in healing wounds. , 1990, Journal of immunology.

[26]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[27]  J. Folkman,et al.  ANGIOGENESIS: INITIATION AND CONTROL * , 1982, Annals of the New York Academy of Sciences.

[28]  H. Granger,et al.  VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. , 1998, American Journal of Physiology.

[29]  M. Goligorsky,et al.  Podokinesis in endothelial cell migration: role of nitric oxide. , 1998, The American journal of physiology.

[30]  H. Granger,et al.  Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. , 1996, The American journal of physiology.

[31]  M. Shabani,et al.  NITRIC OXIDE SYNTHESIS IS SUPPRESSED IN STEROID- IMPAIRED AND DIABETIC WOUNDS , 1995 .

[32]  A. Passaniti,et al.  A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[33]  A. Barbul,et al.  Arginine enhances wound healing and lymphocyte immune responses in humans. , 1990, Surgery.